満たされていないニーズが癌の再発に対する恐怖に与える影響:横断的および多変量分析
Betülay Kılıç1, Eda Ünal1, Canan Pörücü2
1Gülhane Faculty of Nursing, University of Health Sciences, Ankara, Turkey.
Cancer management and research
|September 2, 2025
まとめ
がんが再発する恐れは,満たされていないニーズと家族に がんがあるという歴史によって高まる. これらの要因に対処することは 癌の生存者を支援する上で極めて重要です
科学分野:
- 腫瘍学
- 心理社会的腫瘍学
- 癌 の 生存 率
背景:
- 再発の恐怖は 癌の生存者の大きな懸念です
- 満たされていない需要は 生存者の心理的苦痛を悪化させる可能性があります
- 社会人口学的な影響を理解することは,標的型支援に不可欠です.
研究 の 目的:
- 癌の再発の恐怖と 満たされていないニーズの流行を 決定する.
- 再発の恐怖,満たされていないニーズ,社会人口学的要因との関連を調査する.
- 再発の恐怖と満たされていないニーズを予測する要因を特定する.
主な方法:
- 147人の癌の生存者を対象とした記述的研究です
- 参加者評価フォーム,がん再発の恐怖 (FCRI) およびがん生存者の満たされていないニーズ (CaSUN-TR) スケールを使用して収集されたデータ.
- 回帰を含む統計的分析が行われました.
主要な成果:
- 癌の家族歴 (p=0. 001) で,再発の恐れが著しく増加した.
- 満たされていない需要は,女性および心理的支援を受ける者の間で高かった (p=0.016; p=0.017).
- 家族歴,満たされていないニーズ,心理的支援は再発の恐怖を予測し,性別,心理的サポート,生活の質は満たされていないニーズを予測しました.
結論:
- 満たされていないニーズが増え 癌の家族歴が 癌の再発への恐れに影響します
- 患者のニーズ,特に家族歴のある患者のニーズを特定し,対処することは臨床的に重要です.
- この研究は 癌の生存者に合わせた 介入の必要性を強調しています
関連する概念動画
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K


